10.89.Z - Production of other food products, not elsewhere classified
10.86.Z - Production of homogenized food products and diet food
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
70.22.Z - Head office activities and management consultancy
71.20.A - Food quality testing and analysis
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,9 | 2,5 | 171,1 |
EBITDA | 1,4 | 2,9 | 111,2 | |
Short time liabilities | 0,4 | 0,4 | 4,2 | |
Income tax | 0 | 42,6 | ||
Equity capital | 2,2 | 3 | 5 | 67,9 |
Operating profit (EBIT) | 0,9 | 2,5 | 167,7 | |
Assets | 3,7 | 4,2 | 5,9 | 40,2 |
Net profit (loss) | 0,3 | 0,8 | 2,3 | 171,1 |
Cash | 1,1 | 2,2 | 98,2 | |
Net income from sale | 4,4 | 7,4 | 68,7 | |
Liabilities and provisions for liabilities | 1,5 | 1,2 | 0,9 | -26 |
Working assets | 2 | 3 | 5,2 | 71,4 |
Depreciation | 0,5 | 0,5 | 0 | |
Basic operational activity income | 2,9 | 59 | ||
% | % | % | p.p. | |
Profitability of capital | 14,8 | 28,2 | 45,5 | 17,3 |
Equity capital to total assets | 59,6 | 70,5 | 84,4 | 13,9 |
Gross profit margin | 12,2 | 20,9 | 33,7 | 12,8 |
EBITDA Margin | 31,7 | 39,7 | 8 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 22 | -13 | |
Current financial liquidity indicator | 2.441107988357544 | 5.654900074005127 | 3,3 | |
Net dept to EBITDA | -0.7567984461784363 | -0.7544246912002563 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane